2025 Georgia Codes – Page 200

The controlled substances listed in this Code section are included in Schedule V:
(1) Any compound, mixture, or preparation containing limited quantities of any of the following narcotic
drugs, or salts thereof, which also contains one or more nonnarcotic, active, medicinal ingredients in suf-
ficient proportion to confer upon the compound, mixture, or preparation valuable medicinal qualities other
than those possessed by the narcotic drug alone:
(A) Not more than 200 milligrams of codeine, or any of its salts, per 100 milliliters or per 100 grams;
(B) Not more than 100 milligrams of dihydrocodeine, or any of its salts, per 100 milliliters or per 100 grams;
(C) Not more than 100 milligrams of ethylmorphine, or any of its salts, per 100 milliliters or per 100 grams;
(D) Not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per
dosage unit;
(E) Not more than 100 milligrams of opium per 100 milliliters or per 100 grams;
(1.25) Cenobamate, including its salts;
(1.5) Ganaxolone;
(2) Lacosamide;
(3) Pregabalin;
(4) Pyrovalerone;
(5) Pseudoephedrine as an exempt over-the-counter Schedule V controlled substance distributed in the same
manner as set forth in Code Section 16-13-29.2; provided, however, that such exemption shall take effect
immediately and shall not require rule making by the State Board of Pharmacy; provided, further, that
wholesale drug distributors located within this state and licensed by the State Board of Pharmacy and which
are registered and regulated by the DEA shall not be subject to any board requirements for controlled sub-
stances for the storage, reporting, record keeping, or physical security of drug products containing pseudo-
ephedrine which are more stringent than those included in DEA regulations;
(6) Ezogabine;
(7) Brivaracetam; or
(8) Lasmiditan, including its salts, isomers, and salts of isomers.